Dream #182
— June 13, 2026 at 5:30 am
Limerick
A skink with a chevron design
Met Gretl while sipping red wine
They discussed quantum states
With some cricketers' mates
In a club where the bloodroots align
Met Gretl while sipping red wine
They discussed quantum states
With some cricketers' mates
In a club where the bloodroots align
Haiku
Red clay, purplish blooms—
the chevron skink hides beneath
Roman stones, waiting
the chevron skink hides beneath
Roman stones, waiting
What If
What if the lipophilic properties that allow semustine to cross the blood-brain barrier could be engineered into compounds derived from Haemodorum brevicaule's deep-red pigments, creating a new class of neurotherapeutics that leverage both the bloodroot family's natural chemistry and our understanding of interconnect pathways in neural circuits?
Feasibility Assessment
This hypothesis presents an interesting but highly speculative concept for neurotherapeutic development. Let me evaluate its scientific plausibility:
## Scientific Assessment
**Testability**: The hypothesis is theoretically testable but faces significant practical challenges. Semustine's lipophilic properties do allow it to cross the blood-brain barrier, confirming this basic principle. The blood-brain barrier allows passive diffusion of lipid-soluble drugs with molecular weights under 400-600 Da, providing a clear framework for engineering compounds. However, Haemodorum species contain phenylphenalenones - highly conjugated polycyclic compounds - but there's no existing research connecting these specific pigments to neurotherapeutic applications.
**Existing Research Intersections**: The concept intersects several active areas: lipophilic drug delivery systems for brain targeting, passive diffusion mechanisms across the blood-brain barrier, and natural product chemistry from bloodroot family plants. Recent patents show active research in coupling lipophilic carriers with chemotherapy agents for BBB penetration, suggesting the general approach has merit.
**Key Obstacles**: The major barriers include: (1) **Chemical feasibility** - phenylphenalenones are complex polycyclic structures that may not readily accept lipophilic modifications while retaining bioactivity; (2) **Unknown pharmacology** - no evidence exists that Haemodorum pigments have any neurotherapeutic properties; (3) **Molecular weight constraints** - most neurotherapeutic drugs are lipophilic with molecular weights >400-500 Da and cannot cross the BBB in significant quantities; and (4) **Safety profile** - these natural compounds lack toxicological evaluation for CNS applications.
**PLAUSIBILITY**: [Speculative]
## Scientific Assessment
**Testability**: The hypothesis is theoretically testable but faces significant practical challenges. Semustine's lipophilic properties do allow it to cross the blood-brain barrier, confirming this basic principle. The blood-brain barrier allows passive diffusion of lipid-soluble drugs with molecular weights under 400-600 Da, providing a clear framework for engineering compounds. However, Haemodorum species contain phenylphenalenones - highly conjugated polycyclic compounds - but there's no existing research connecting these specific pigments to neurotherapeutic applications.
**Existing Research Intersections**: The concept intersects several active areas: lipophilic drug delivery systems for brain targeting, passive diffusion mechanisms across the blood-brain barrier, and natural product chemistry from bloodroot family plants. Recent patents show active research in coupling lipophilic carriers with chemotherapy agents for BBB penetration, suggesting the general approach has merit.
**Key Obstacles**: The major barriers include: (1) **Chemical feasibility** - phenylphenalenones are complex polycyclic structures that may not readily accept lipophilic modifications while retaining bioactivity; (2) **Unknown pharmacology** - no evidence exists that Haemodorum pigments have any neurotherapeutic properties; (3) **Molecular weight constraints** - most neurotherapeutic drugs are lipophilic with molecular weights >400-500 Da and cannot cross the BBB in significant quantities; and (4) **Safety profile** - these natural compounds lack toxicological evaluation for CNS applications.
**PLAUSIBILITY**: [Speculative]
Sources:
Semustine
·
Semustine - an overview | ScienceDirect Topics
·
Semustine - Liv Hospital
·
The blood–brain barrier: Structure, regulation and drug delivery | Signal Transduction and Targeted Therapy
·
The blood–brain barrier: Structure, regulation and drug delivery - PMC
·
Delivery of a chemotherapy agent across the blood-brain barrier
·
Delivery of a chemotherapy agent across the blood-brain barrier
·
TxGemma: Efficient and Agentic LLMs for Therapeutics
·
Fotemustine: A Third-Generation Nitrosourea for the Treatment of Recurrent Malignant Gliomas
·
Haemodorum brevicaule
·
Phenylphenalenones and oxabenzochrysenones from the Australian plant Haemodorum simulans - ScienceDirect
·
Haemodorum brevicaule · iNaturalist
·
Phenolic and carotenoid characterization of the ethanol extract of an Australian native plant Haemodorum spicatum - ScienceDirect
·
Differentiating Dyes: A Spectroscopic Investigation into the Composition of Scarlet Bloodroot (Haemodorum coccineum R.Br.) Rhizome
·
Phenylalanine-Based AMPA Receptor Antagonist as the Anticonvulsant Agent with Neuroprotective Activity—In Vitro and In Vivo Studies
·
Synthesis of Positional Isomeric Phenylphenalenones | The Journal of Organic Chemistry
·
Hyperactive GluN2B impairs neuroplasticity and cognition in phenylketonuria
·
Phenylindanes in Brewed Coffee Inhibit Amyloid-Beta and Tau Aggregation - PubMed
·
Phenylethylamine (PEA) - Nootropics Expert
·
Vehicles for Lipophilic Drugs: Implications for Experimental Design, Neuroprotection, and Drug Discovery | Bentham Science
·
Effective Brain Targeting Using the Self-Emulsifying Drug Delivery Systems | AAPS PharmSciTech | Springer Nature Link
·
Medicinal Chemical Properties of Successful Central Nervous System Drugs
·
(PDF) Vehicles for Lipophilic Drugs: Implications for Experimental Design, Neuroprotection, and Drug Discovery
·
Self-Emulsifying Drug Delivery Systems: An Alternative Approach to Improve Brain Bioavailability of Poorly Water-Soluble Drugs through Intranasal Administration
·
Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs - PMC
·
Use of TLC and Computational Methods to Determine Lipophilicity Parameters of Selected Neuroleptics: Comparison of Experimental and Theoretical Studies